Lv2
116 积分 2022-04-24 加入
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
2天前
已完结
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer
2天前
已完结
Docetaxel as part of first-line chemotherapy for gastric cancer
2天前
已完结
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer
1个月前
已完结
Rethinking fairness in AI to improve current practice in oncology
1个月前
已关闭
BRAF oncogenic mutants evade autoinhibition through a common mechanism
3个月前
已完结
Rethinking fairness in AI to improve current practice in oncology
3个月前
已关闭
Metabolism-programming mRNA-lipid nanoparticles remodel the immune microenvironment to improve immunotherapy against MAFLD
3个月前
已完结
Adverse cardiac events associated with antibody-drug conjugates in cancer patients: retrospective analysis of FAERS database and RCTs
3个月前
已完结
Cardiovascular toxicity of immune therapies for cancer
3个月前
已完结
皖公网安备34019202002308
